Since Stat3 inhibition also blocks VEGF expression in tumours characterized by aberrant activation of Src [77], therapeutic targeting of Stat3 may inhibit neovascularisation in tumours associated with excessive signaling through epidermal growth factor receptor. This evidence concerns the gene VEGFA and neoplasm.